Effects of Buprenorphine and Naloxone in Opiate Addicts - 4

Effects of Buprenophine and Naloxone in Opiate Addicts

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00000355

Enrollment

Registered

1999-09-21

Start date

1994-11-30

Completion date

1996-03-31

Last updated

2017-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid-Related Disorders, Substance-Related Disorders

Keywords

opiate dependence

Brief summary

The purpose of this study is to evaluate the behavioral and physiological effects of buprenorphine and naloxone, both alone and in combination.

Interventions

DRUGBuprenorphine

Study design

Primary purpose

TREATMENT

Eligibility

Sex/Gender

ALL

Age

21 Years to 59 Years

Healthy volunteers

Inclusion criteria

Please contact site for information.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026